The Effect of Assisted Reproductive Technology on Male Sexual Function.
- Conditions
- Erectile Dysfunction
- Interventions
- Other: Questionnaire and personal interviews.
- Registration Number
- NCT04338087
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
Men participating in assisted reproductive technology treatments will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth.
- Detailed Description
Men participating in fertility will be recruited to a study involving filling erectile function questionnaires throughout fertility treatments, pregnancy and up to 1 year after birth. In addition, participants will be questioned regarding marital life, sexual intercourse frequency, medical history and treatments for erectile dysfunction in relevant cases. Thes control group will be comprised of male subjects who did not require fertility treatments to conceive.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 734
- Participation in fertility treatments.
- None.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Fertility treatments Questionnaire and personal interviews. Men participating in fertility treatments. Spontaneous pregnancy Questionnaire and personal interviews. Men whose wives conceived spontaneously.
- Primary Outcome Measures
Name Time Method Changes in International index of erectile function score From recruitment up to 3 years. Changes in International index of erectile function score with a possible score ranging from 0 to 75. The higher the score, the better erectile function is.
- Secondary Outcome Measures
Name Time Method Sexual intercourse rate. From recruitment up to 3 years. Sexual intercourse rate as measured by the average monthly intercourse rate.
Use of phospho-di-esterase 5 inhibitors From recruitment up to 3 years. Use of phospho-di-esterase 5 inhibitors as measured by the number of men using this medication.
Trial Locations
- Locations (1)
Rambam healthcare campus
🇮🇱Haifa, Israel